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Summary Although matrix metalloproteinases (MMPs) are among the potential key mediators of cancer invasion, their involvement in
premalignant lesions and conditions is not clarified. Therefore, we studied, using in situ hybridization, immunohistochemistry and zymography
the expression and distribution of MMP-1 and -2, and their tissue inhibitors (TIMPs -1, -2 and -3) in oral squamous cell carcinomas (SCC) and
lymph node metastases as well as in oral lichen planus, epithelial dysplasias and normal buccal mucosa. In oral SCC and lymph node
metastasis, MMP-1 mRNA was detected in fibroblastic cells of tumoral stroma. In two out of ten carcinomas studied, the peripheral cells of
neoplastic islands were also positive. MMP-2 mRNA expression was noted in fibroblasts surrounding the carcinoma cells, and no signal in
carcinoma cells was detected. A clearTIMP-3 mRNA expression was seen in stromal cells surrounding the neoplastic islands in all SCCs and
lymph node metastases studied. TIMP-1 mRNA was detected in some stromal cells surrounding the neoplastic islands, whereas the mRNA
expression for TIMP-2 was negligible. On the other hand, expression of MMPs and TIMPs was consistently low in oral epithelial dysplasias,
lichen planus and normal mucosa. In certain epithelial dysplasias and lichen planus, MMP-1 and -2 mRNA expressions were detected in few
fibroblasts under the basement membrane zone, but normal mucosa was completely negative. In SCC and lymph node metastasis, a
detectable immunostaining for MMP-1 in stromal cells and in some carcinoma cells was observed. MMP-2 immunoreactivity was detected in
the peripheral cell layer in neoplastic islands and in some fibroblast-like cells of tumoral stroma. Immunostaining for TIMP-3 was detected in
stromal cells surrounding the neoplastic islands. A weak positive staining for TIMP-1 was located in tumoral stroma, whereas the
immunostaining for TIMP-2 was negative. Using zymography, elevated levels of MMP-2 and MMP-9 were observed in carcinoma samples in
comparison with lichen planus or normal oral mucosa. Our results indicate that the studied MMPs and TIMPs are clearly up-regulated during
invasion in oral SCC. However, there was also a clear, although weak, up-regulation of the expression of the MMPs but not TIMPs in some of
the lichen planus and dysplastic lesions.
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Oral squamous cell carcinoma (SCC) has a high potential for inva-
siveness associated with a high rate offatality. Distant-organ metas-
tasis and regional lymph node metastasis are the major cause of
mortality from the oral SCC. Oral lichen planus is regarded as a
potential condition for malignant transformation, and thus dysplasia
or carcinoma could arise from oral lichen planus (WHO, 1997).
Matrix metalloproteinases (MMPs) are a highly regulated super-
family ofenzymes that degrade almost all extracellular matrix and
basement membrane components, processes which are essential for
invasion and subsequent metastasis (Liotta et al, 1980; Tryggvason
et al, 1987; Chambers and Matrisian, 1997). Among the MMPs,
type I collagenase (MMP-1 or interstitial collagenase) degrades the
fibrillar collagens and thus is important for the tumour traversing
the extracellular space. A 72-kDa type IV collagenase (MMP-2)
and a 92-kDa type IV collagenase (MMP-9) degrade type IV
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collagen present in basement membranes and have been implicated
in the invasion of several tumour types, including skin and breast
cancers (Fessler et al, 1984; Murphy et al, 1989; Monteagudo et al,
1990; Pyke et al, 1992). MMP-2 and MMP-9 also degrade native
type V, VII and X collagens, fibronectin, elastin and gelatin (Seltzer
et al, 1989; Senior et al, 1991).
The activity ofMMPs is regulated, in part, by tissue inhibitors of
metalloproteinases (TIMPs) (Docherty and Murphy, 1990; Stetler-
Stevenson et al, 1990). Imbalances in the extracellular activities of
MMPs and TIMPs have been linked with pathological tissue
destruction seen in cancer, arthritis and cardiovascular disease
(Liotta et al, 1991; Brinckerhoff 1992; Armstrong et al, 1994).
TIMPs have potent antiangiogenic properties and can suppress
tumour invasion and metastasis (Liotta et al, 1991; DeClerck et al,
1992). Among the TIMPs the best known are TIMP-1, -2 and -3
(Welgus and Stricklin, 1983; Stetler-Stevenson et al, 1989; Apte et
al, 1994). More recently, an additional member ofthe TIMP family,
called TIMP-4, has been isolated (Greene et al, 1996).
Regarding the in vivo involvement of MMPs and their
inhibitors in human oral cancers, little information has been
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Figure 1 mRNA expression of MMP-1, MMP-2, TIMP-1 and TIMP-3 in oral squamous cell carcinoma studied by in situ hybridization. MMP-1 mRNA is
expressed by stromal cells surrounding the neoplastic islands (arrows) (A and B). MMP-2 gene expression is detected in fibroblast-like cells of tumoral stroma
(C and D). TIMP-1 mRNA is found in some stromal cells (E and F), whereas a clear TIMP-3 mRNA expression is seen in stromal cells surrounding the
neoplastic islands (G and H). (Magnifications x 250; B, D, F and H are dark-field images)
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presented. In SCCs, MMP-1 mRNA expression has been shown in
stromal cells and in cancer cells of tumour islands (Polette et al,
1991; Gray et al, 1992; Muller et al, 1993). In human skin cancers,
MMP-9 is synthesized by the tumour cells, whereas MMP-2 is
derived from the stromal cells surrounding the neoplastic islands
(Pyke et al, 1992). Among the TIMPs, in oral SCC, a low TIMP-1
gene expression has been reported in fibrous connective tissue
(Gray et al, 1992) and also in well-differentiated cancer cells and
in endothelial cells, whereas TIMP-2 mRNA was localized in a
few stromal cells near invasive cancercells and in endothelial cells
as well (Polette et al, 1993). To our knowledge there are no earlier
reports from TIMP-3 expression in oral lesions.
MMPs are thought to be key enzymes mediating cancer inva-
sion, but their roles in premalignant lesions and conditions are less
clear. With this background we have now investigated the mRNA
expression and protein distribution ofMMP-1 and -2, and TIMP-1,
-2 and -3 in oral SCC and lymph node metastasis. We further
compared the MMP and TIMP expression in carcinoma with their
expression in oral epithelial dysplasias, lichen planus and normal
buccal mucosa. The aim of the zymography and enhanced chemi-
luminescence (ECL) Western blots was to find out if there were
some differences in MMP amounts and the degree of conversion
of latent MMPs to active counterparts between SCC, lichen planus
and normal oral mucosa.
MATERIALS AND METHODS
Oral biopsy specimens of ten SCCs, ten lymph node metastases,
ten lichen planus, six epithelial dysplasias and four normal buccal
mucosa were included in the study. SCCs were graded histologi-
cally as well-moderately (n = 6) and poorly differentiated (n = 4)
(Wahi et al, 1971). Dysplasias were graded as mild (n = 4) and
moderate (n = 2) (Who Collaborating Centre for Oral
Precancerous Lesions, 1978). Diagnosis of lichen planus was
based on clinical and histopathological criteria. The investigation
was approved by the Ethics Committee ofthe University ofOulu.
RNA probes and in situ hybridization
Paraffin sections (4gm) were used for in situ hybridization. A
detailed description of the preparation of paraffin sections for
in situ hybridization has been described previously (Autio-
Harmainen et al, 1992). A 1017-bp EcoRI-BamHI fragment of
MMP-1 cDNA clone (Goldberg et al, 1986) was ligated in the
pGEM 4Z vector. A 635-bp Scal-Sacl fragment ofhuman MMP-2
cDNA clone (Huhtala et al, 1990) was cloned into the M13
polylinker site of pSP64 and pSP65 vectors. A 626-bp
BamHI-HindIII fragment of TIMP-1 coding sequence was cut
from the pUC 19 vector. Originally, the TIMP-1 cDNA, described
by Docherty et al (1985) and Carmichael et al (1986) was ampli-
fied by polymerase chain reaction (PCR) using the available
sequence data from the GenBank. This cDNA fragment was
ligated in pGEM 4Z vector. A 388-bp EcoRI-KpnI fragment ofthe
human TIMP-2 cDNA clone, described by Stetler-Stevenson et al
(1990) from pSS 38 vector was ligated in pGEM 4Z vector. A
500-bp EcoRI-PstI fragment of the human TIMP-3 cDNA clone
described by Apte et al (1994) was ligated in pGEM 4Z vector.
Vectors were linearized with suitable restriction enzymes, and for
transcription a riboprobe trancription kit (Promega) was used and
the transcripts were labelled by [35S]UTP to specific activities of
3 x 106c.p.m. per40 pl. Solutions were treated with0.1% diethylpy-
rocarbonate. All the probes have been tested by Northern hybridiza-
tion (data not shown) and by sequencing the whole cDNA.
In situ hybridization with antisense and sense RNA probes has
been described previously (Autio-Harmainen et al, 1992). The
hybridizations were performed at 50°C, followed by washing,
autoradiography for 7-15 days, and staining of the sections with
haematoxylin and eosin.
Immunohistochemical staining
Paraffin sections (6 gm) were washed in phosphate-buffered saline
(PBS) for 10 min. Non-specific binding ofIgGs was blocked using
normal rabbit serum (1:20 in PBS with 0.1% bovine serum
albumin, BSA). The sections were incubated overnight with
primary antibody at 4°C. Negative controls were stained with PBS
and normal mouse or rabbit IgG instead of the primary antibody.
The sections were then incubated (30 min) with biotinylated anti-
mouse or anti-rabbit IgG secondary antibody (Vector Elite kit,
Abbott, Chicago, IL, USA), the avidin-peroxidase complex
(30 min), and the substrate (0.05% 3,3-diaminobenzidine tetra
hydrochloride (DAB) in Tris buffer, pH 7.4); (Sigma, Poole, UK)
(4 min). A DAB enhancing solution (Vector Laboratories,
Burlingame, CA, USA) was used according to product protocol to
intensify stain in some stainings. For morphological observation
haematoxylin routine histological stain was used.
Primary antibodies against the following molecules were used:
polyclonal antibodies against MMP-1, 1:100 (Goldberg et al,
1986); MMP-2, 1:200 (Wallon and Overall, 1997); TIMP-1, 1:200
(Bodden et al, 1994); TIMP-3, 1:500 (Triple Point Biologics, OR,
USA) and monoclonal antibody against TIMP-2, 1:200 (Hoyhtya
et al, 1994).
Assay of gelatinase by zymography
Gelatinases from 25-gm-thick and same size frozen tissue sections
homogenized in sample buffer were assayed using the zymog-
raphy method described previously (Salo et al, 1991).
Zymography was performed in 1.5-mm 10% polyacrylamide slab
gels containing 1 mg ml-' gelatin labelled with 2-methoxy-2,4-
diphenyl-3(2H)-furanone (Fluka, Ronkonkoma, NY, USA). The
gels were photographed under long-wave ultraviolet illumination.
We estimated cleavage rates by densitometric scanning, from
negatives of the photographed gels, using a Computing
Densitometer model 300A (Molecular Dynamics, CA, USA).
Western blotting
For Western analysis, 25-gm-thick and same size frozen tissue
sections homogenized to sample buffer were run on 10% SDS-
polyacrylamide gel, and transferred to nitrocellulose filters
(Schleicher & Schuell, Dassel, Germany) or Immobilon-P PVDF
transfer membrane (Millipore Corporation, Bedford, MA, USA).
Non-specific binding was blocked by incubation with tris-buffered
saline (TBS) supplemented with 10% non-fat dry milk (Difco
Laboratories, Detroit, MI, USA) for 60 min. After washing, the
filters were incubated with primary antibodies (MMP-1, MMP-2,
TIMP-1, TIMP-2, TIMP-3) (1:500) overnight at 4°C. After
washing, the filters were incubated with biotinylated secondary
antibody (1:500, Dako, Glostrup, Denmark) for I h at room
temperature. After washing, the filters were incubated with the
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Figure 2 mRNA expression of MMP-1 in oral epithelial dysplasia studied by in situ hybridization. MMP-1 mRNA is detected in few fibroblasts under the
basement membrane (arrows) (A and B). (Magnifications x 250; B is dark-field image)
avidin-peroxidase complex for 45 min. ECL Chemiluminescence
Western Blotting detection kit (Amersham LifeScience,
Buckinghamshire, UK) was used as described in the product
protocol. In the method, the chemiluminescence reaction produced
by ECL reagents was detected using autoradiography.
RESULTS
In situ hybridization
In situ hybridization experiments were carried out on ten oral
SCCs, ten lymph node metastases, six epithelial dysplasias, ten
lichen planus and four normal buccal mucosa, using antisense
RNA probes specific to MMP-1, -2, and TIMP-1, -2 and -3.
In all oral SCC samples, MMP-1 mRNA was observed in
fibroblastic cells of tumoral stroma (Figure 1A and B). In two out
of ten cases, the expression was also detected in cancer cells in
which MMP-1 gene expression was restricted to the peripheral
cells ofneoplastic islands (data not shown). In lymph node metas-
tasis, the expression was detected in fibroblast-like cells in tumoral
stroma (data not shown). In oral lichen planus and dysplastic
lesions, the MMP-I mRNA expression was low. In two out of six
epithelial dysplasias and in one out of ten lichen planus studied,
few fibroblasts under the basement membrane were positive
(Figure 2A and B). In normal oral mucosa, the expression for
MMP-l was negative.
MMP-2 mRNA expression was noted in fibroblasts surrounding
the tumour cells in invasive SCC (Figure IC and D) and lymph
node metastasis. Malignant cells were negative in all cases. In oral
normal mucosa and lichen planus, the mRNA expression was not
detected (data not shown). In two out of six dysplastic lesions
studied, few positive fibroblasts were seen (data not shown).
In SCC and in lymph node metastasis, modest TIMP-1 expres-
sion was noted in stromal cells surrounding the neoplastic islands
(Figure 1E and F). No TIMP-1 mRNA expression was detected in
oral normal mucosa, lichen planus or dysplastic lesions (data not
shown). TIMP-2 gene expression was not detected in any of the
samples studied (data not shown).
In invasive SCC and lymph node metastasis, a clear TIMP-3
expression was noted in stromal cells surrounding the neoplastic
islands (Figure IG and H). Little or no mRNA for TIMP-3 was
detected in oral normal mucosa, lichen planus or dysplastic lesions
(data not shown).
As a negative control, sense RNA probes were applied to
adjacent sections of all specimens. In these sections, no signal
was seen (data not shown).
Immunohistochemistry
Oral SCCs and lymph node metastasis were studied by immuno-
histochemical staining using specific antibodies to MMPs (MMP-
1 and -2) and TIMPs (TIMP-1, -2 and -3).
In SCC and lymph node metastasis, there was adetectable staining
reaction forMMP-1 in stromal cells and also in some carcinomacells
(Figure 3A). Immunostaining for MMP-2 was detected in theperiph-
eral cell layer in neoplastic islands and in some fibroblast-like cells of
tumoral stroma (Figure 3B). Endothelial cells stained consistently
well with MMP-2 antibody. In lymph node metastasis, positive
MMP-2 immunostaining was seen in some tumour cells (Figure 3C).
A weak positive staining reaction forTIMP-1 was located in tumoral
stroma, whereas the staining for TIMP-2 was negative (data not
shown). There was a clear immunostaining reaction for TIMP-3 in
stromal cells surrounding the neoplastic islands (Figure 3D).
Zymography
Zymography offive oral SCC samples is shown in Figure 4A. Strong
pro-MMP-9 was found in all SCC samples studied, whereas active
MMP-9 species were weaker and seem to vary between different
samples. In the studied carcinomas, MMP-9 dominated MMP-2, and
active MMP-2 species dominated latent species. Clearly, moregelati-
nases were detected in SCC in relation to lichen planus and normal
mucosa (Figure 4B). In normal mucosa, gelatinases existed pre-
dominantly as inactive latent proforms. In lichen planus, gelatinase
intensities were between normal mucosa and carcinoma sample.
In ECL-Western blotting with anti-MMP-2, both latent and active
species were identified and their intensities corresponded to those
detected by zymography. With anti-MMP-1, the strongest band was
seen in oral SCC compared with lichen planus and normal mucosa.
In ECL-Westem blots with TIMP-antibodies, small 20-30 kDa
British Journal of Cancer (1998) 77(12), 2239-2245 0 Cancer Research Campaign 1998
ioF A AP
444 1"... .-
''I ...-Y.MMPs and TIMPs in oral lesions 2243
B A
im..
Figure 3 Immunohistochemical stainings of MMP-1, MMP-2, and TIMP-3 in oral squamous cell carcinoma. A detectable staining reaction for MMP-1 is seen in
stromal cells and also in some carcinoma cells (A). Immunostaining for MMP-2 was detected in peripheral cell layer in neoplastic islands and in some fibroblast-
like cells of tumoral stroma (B). In lymph node metastasis, positive MMP-2 immunostaining was seen in some tumour cells (C). There was a clear
immunostaining reaction for TIMP-3 in stromal cells surrounding the neoplastic islands (D). (In D a DAB enhancing solution was used; magnifications x 250)
molecular weight bands were not detected. SDS-PAGE analysis
using Coomassie brilliant blue staining demonstrated similar protein
content ofthe sample groups studied (data not shown).
DISCUSSION
We studied, using in situ hybridization and immunohistochemistry,
the expression and distribution of MMP- 1 and -2, and their tissue
inhibitors (TIMP-1, -2 and -3) in oral SCCs and lymph node
metastasis. The expression was also studied in oral lichen planus,
epithelial dysplasias and normal buccal mucosa. Tissue samples
were also investigated using zymography and ECL-Western blots
to find out whether there are any differences in MMP amounts and
the degree of conversion of latent MMPs to active counterparts
between SCC, lichen planus and normal oral mucosa.
To our knowledge there are no earlier reports from TIMP-3
distribution in oral lesions. In oral SCC and lymph node metas-
tasis, strong TIMP-3 expression was found in stromal cells
surrounding the neoplastic islands. In addition to inhibitory
activity, it has been suggested that TIMP-3 has a possible role in
connective tissue turnover and remodelling (Urfa et al, 1994).
However, Sun et al (1996) have recently shown that TIMP-3 over-
expression in mouse epidermal cells had no effect on growth,
tumorigenity or invasion and did not reverse tumour cell pheno-
type in tumour cells lacking endogenous TIMP-3.
Previous reports have indicated that MMP-1 is synthesized by
stromal cells and in some cases also by tumour cells in oral SCC
(Gray et al, 1992; Muller et al, 1993). In our studies from oral SCC
and lymph node metastasis, stromal cells and peripheral cells in
neoplastic islands expressed MMP-1 mRNA. There was a
detectable immunostaining reaction for MMP-1 in stromal cells
and also in some carcinoma cells. MMP-1 is highly active against
interstitial collagen and is thus important for the tumours to
traverse the extracellular space and tumour invasion.
Our results of MMP-2 mRNA expression in oral SCC, lymph
node metastasis, lichen planus and epithelial dysplasias are in line
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Figure 4 Zymography of oral squamous cell carcinoma, lichen planus and
normal mucosa. (A) Strong pro-MMP-9 is found in all squamous cell
carcinoma samples studied, whereas active MMP-9 species are weaker and
seem to vary between different samples. In these carcinomas, MMP-9
dominates MMP-2, and active MMP-2 species dominate latent species.
(B) Clearly more gelatinases are detected in squamous cell carcinoma (lane
1) than in lichen planus (lane 2) and normal oral mucosa (lane 3). In normal
mucosa, gelatinases exist predominantly as inactive latent proforms. In lichen
planus, gelatinase intensities were between normal mucosa and carcinoma
sample
with Pyke et al (1992), who showed by using in situ hybridization
that a 72-kDa type IV collagenase is derived from the stromal cells
surrounding the tumour cells in human skin cancers. The mRNA
expression ofMMP-2 in lymph node metastasis correlates with the
expression in oral SCC, and thus confirms and further extends the
role of this enzyme in tumour invasion. However, in our study
clear immunostaining for MMP-2 was detected in peripheral cell
layer in neoplastic islands and in some fibroblast-like cells of
tumoral stroma in SCC. In epithelial dysplasias and lichen planus,
slight MMP-1 and -2 mRNA expression was locally found under
the basement membrane. These enzymes are capable ofdegrading
the basement membrane components and this could thus, at least
in theory, help in cancer progression.
According to previous studies of oral SCC, hyperplastic and
dysplastic lesions, TIMP-1 gene expression was low and negli-
gible with grains scattered throughout the fibrous connective
tissue of all non-neoplastic epithelia examined, as it was in all the
neoplastic tissues investigated (Gray et al, 1992). However, in
epidermoid head and neck carcinomas, Polette et al (1993) found
TIMP-1 mRNA expression in well-differentiated cancer cells and
in endothelial cells, whereas TIMP-2 mRNA was localized in a
few stromal cells near invasive cancer cells and in endothelial cells
as well. In our present investigation, in SCC and lymph node
metastasis, TIMP-1 mRNA expression was detected in some
stromal cells surrounding the neoplastic islands and weak positive
immunostaining was located in tumoral stroma. TIMP-2 was
negative in all carcinoma and lymph node metastasis studied.
MMP and TIMP expressions were consistently low in lichen
planus, and mild and moderate epithelial dysplasias studied. In
normal buccal mucosa, the expressions were negative.
We also homogenized frozen tissue sections directly into
sample buffer without any purification. When gelatinolytic activi-
ties present in oral SCC, lichen planus and normal mucosa were
compared, significantly more gelatinase activities were detected in
carcinoma than in lichen planus and normal mucosa. In carcinoma,
the active MMP-2 species clearly dominated the latent ones, but in
normal mucosa, intensities were vice versa. In carcinoma, latent
MMP-9 species dominated active ones, whereas in normal mucosa
the overall amount of MMP-9 was weak. In lichen planus, gelati-
nase intensities were between normal mucosa and carcinoma
sample. In zymography of SCC, many gelatinases with different
molecular sizes were found, and the ECL-Western blot was used to
identify MMP-2. Latent and active MMP-2 were identified and
their intensities corresponded to zymographic findings. With anti-
MMP-1, the strongest band was seen in oral SCC compared with
lichen planus and normal mucosa. With TIMP-antibodies, small
20-30 kDa molecular weight bands were not found in homoge-
nized frozen tissue samples. In all ECL-Western blots carried out,
many high-molecular-weight bands were found. These bands did
not correspond to the well-known molecular weights of MMPs
and TIMPs studied. The bands might be the results of the
protein-protein interactions (i.e. MMP-TIMP complexes) in
tissue samples and there might also be some non-specific binding
ofECL reagents.
MMPs have long been associated with metastasis, and there is
no doubt that they are major functional contributors to the
metastatic process. It has been suggested that MMPs are important
in creating and maintaining an environment that supports the initi-
ation and maintenance of growth of primary and metastatic
tumours. MMPs and their inhibitors appear to be importantregula-
tors of the growth of tumours, both at the primary state and as
metastases (Chambers and Matrisian, 1997). Some ofthese activi-
ties may be derived from tumour-associated host tissues as a host
response to the presence of invasive malignant cells, as suggested
by Poulsom et al (1993).
It seems that the MMPs and TIMPs studied are involved in
extracellular matrix remodelling during cancer invasion in oral
SCC. We found slight but clear MMP-1 and MMP-2 mRNA
expression in oral premalignancies; theseexpressions were weaker
in relation to oral SCC. We conclude that in oral SCC similarly to
human skin and other carcinoma types, regulation ofextracellular
matrix remodelling during cancer invasion is the result of a
concerted action ofMMPs and TIMPs.
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